Related Experiment Video
Updated: Feb 18, 2026

09:01
An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
8.4K
Rubella in Denmark
1Statens Serum Institut, Copenhagen, Denmark.
Summary
Denmark
Area of Science:
- Public Health
- Infectious Disease Epidemiology
- Vaccinology
Background:
- Rubella (German measles) incidence in Denmark averaged 20,000 cases annually until 1987.
- A significant decline to 1006 cases in 1989 indicated successful public health interventions.
- Current rubella incidence is considered very low, below 1 per 100,000 population.
Purpose of the Study:
- To assess the impact of vaccination strategies on rubella incidence in Denmark.
- To evaluate the sustainability of low rubella rates.
- To consider future steps for rubella control aligned with WHO goals.
Main Methods:
- Analysis of historical rubella case data in Denmark.
- Review of vaccination program implementation dates and policies.
- Examination of notifiable disease status changes for rubella-related conditions.
Main Results:
- Rubella incidence dramatically decreased following the initiation of rubella vaccination for women of childbearing age in 1980.
- Further reductions were observed with the refunding of childhood vaccinations in 1982 and the introduction of the Measles, Mumps, and Rubella (MMR) vaccine in 1987.
- Congenital rubella syndrome and rubella in pregnancy became notifiable diseases in 1994, contributing to sustained low incidence.
Conclusions:
- Vaccination programs, particularly targeting women and children, have been highly effective in reducing rubella incidence in Denmark.
- The current low incidence is sustainable through ongoing vaccination efforts and disease surveillance.
- Mandatory reporting of laboratory-diagnosed rubella cases is being considered to meet World Health Organization (WHO) rubella control objectives.
Related Concept Videos
Rh Blood Group
3.5K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
3.5K
Vaccinations
52.0K
Overview
52.0K
Development of Immunocompetence
1.0K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.0K

